Inside the FDA: Andreas Schick on the Future of GenAI

In this episode of The Peel Podcast, host Shelley McGuire chats with Andreas Schick, Director and Data Scientist at the FDA, for a candid conversation about how AI, machine learning, and GenAI are reshaping public health. The two dive into how emerging technologies are being used across FDA workflows, how leaders are interacting with data in new ways, and what it really takes for teams to adopt and trust GenAI tools. Andreas shares insights on balancing innovation with responsible governance, the impact of new federal guidance, and how FDA is thinking about competitiveness, openness, and risk in this rapidly changing landscape. He also highlights early success stories and practical wins already taking shape inside the agency. To connect with Andreas, follow him on LinkedIn here.